If it was earning a bit more revenue and was that little bit more advanced it would be worth a $50m MC easily.
Other similar stocks like IME, M7T, PME, ALC and other med tach companies have tripled in value over the last few months.
EMV has stayed the same around that $20m MC.
Just needs a bit more news flow to get it nearer to commercialisation and it should fly. The difference here is the revenues should be fast and substantial as compared to slow and steady for the more traditional medical imaging stocks.
EMvision Research Notes, page-26
-
- There are more pages in this discussion • 2,636 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
